Question 1

Am I eligible for this trial based on my current health and cancer stage?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Impact of Margin-accentuation IRE in Pancreatic Cancer clinical trial (NCT02952859). Contact the study team or your healthcare provider for specific answers.

Question 2

How does irreversible electroporation compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Impact of Margin-accentuation IRE in Pancreatic Cancer clinical trial (NCT02952859). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of IRE?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Impact of Margin-accentuation IRE in Pancreatic Cancer clinical trial (NCT02952859). Contact the study team or your healthcare provider for specific answers.

Question 4

How will participating in this trial affect my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Impact of Margin-accentuation IRE in Pancreatic Cancer clinical trial (NCT02952859). Contact the study team or your healthcare provider for specific answers.

Question 5

What is the expected timeline for treatment and follow-up visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Impact of Margin-accentuation IRE in Pancreatic Cancer clinical trial (NCT02952859). Contact the study team or your healthcare provider for specific answers.

What this study is about